Journal
MICROBIOLOGY-SGM
Volume 166, Issue 8, Pages 717-726Publisher
MICROBIOLOGY SOC
DOI: 10.1099/mic.0.000930
Keywords
Acinetobacter baumannii; anti-biofilm; anti-virulence; biofilm-associated protein (Bap); resistance-nodulation-division (RND)-type efflux pump; zerumbone
Categories
Funding
- Soonchunhyang University research fund
- Basic Science Research Program via the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2017R1D1A1B03032960]
Ask authors/readers for more resources
Acinetobacter baumannii is a multidrug-resistant opportunistic pathogen that affects patients with a compromised immune system and is becoming increasingly important as a hospital-derived infection. This pathogen is difficult to treat owing to its intrinsic multidrug resistance and ability to form antimicrobial-tolerant biofilms. In the present study, we aimed to assess the potential use of zerumbone as a novel anti-biofilm and/or anti-virulence agent against A. baumannii. The results showed that zerumbone at sub-inhibitory doses decreased biofilm formation and disrupted established A. baumannii biofilms. The zerumbone-induced decrease in biofilm formation was dose-dependent based on the results of microtitre plate biofilm assays and confocal laser scanning microscopy. In addition, our data validated the anti-virulence efficacy of zerumbone, wherein it significantly interfered with the motility of A. baumannii. To support these phenotypic results, transcriptional analysis revealed that zerumbone downregulated the expression of biofilm- and virulence-associated genes (adeA, adeB, adeC and bap) in A. baumannii. Overall, our findings suggested that zerumbone might be a promising bioactive agent for the treatment of biofilm- and virulence-related infections caused by multidrug-resistant A. baumannii.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available